DAPSOGEL

This brand name is authorized in Ecuador

Active ingredients

The drug DAPSOGEL contains one active pharmaceutical ingredient (API):

1 Dapsone
UNII 8W5C518302 - DAPSONE

Dapsone is a sulfone active against a wide range of bacteria. Dapsones mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms.

Read about Dapsone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D10AX05 D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AX Other anti-acne preparations for topical use
Discover more medicines within D10AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 6449-MEE-0721

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.